The Recombinant Danio rerio Centrosomal protein of 19 kDa (cep19) is a protein derived from zebrafish, produced through recombinant DNA technology. This protein is of significant interest due to its role in centrosomal and ciliary functions, similar to its human counterpart, which is associated with obesity and other metabolic disorders when mutated . The recombinant form allows for the study of its biological functions and potential applications in research and medicine.
The recombinant Danio rerio Centrosomal protein of 19 kDa (cep19) is produced in various expression systems, including yeast, E. coli, baculovirus, and mammalian cells . Each system offers different advantages in terms of yield, purity, and post-translational modifications. For instance, yeast and E. coli systems are often preferred for high yield and cost-effectiveness, while mammalian cells provide more authentic post-translational modifications.
Production System | Advantages | Disadvantages |
---|---|---|
Yeast | High yield, cost-effective | Limited post-translational modifications |
E. coli | High yield, cost-effective | Limited post-translational modifications |
Baculovirus | High yield, suitable for large proteins | Requires insect cells |
Mammalian Cells | Authentic post-translational modifications | Lower yield, higher cost |
The cep19 protein in zebrafish, like its human counterpart, is predicted to be involved in the microtubule cytoskeleton and localized to the cilium, cytoplasm, and cytoskeleton . It plays a crucial role in maintaining cellular structure and function, particularly in processes related to cilia and centrosomes. In humans, mutations in the CEP19 gene have been linked to morbid obesity and spermatogenic failure .
The recombinant Danio rerio Centrosomal protein of 19 kDa (cep19) offers potential for studying obesity and related metabolic disorders. By understanding its role in zebrafish, researchers can gain insights into the conserved mechanisms across species, which could lead to novel therapeutic targets for obesity and other diseases associated with ciliary dysfunction.
Function: Required for ciliation. Recruits the RABL2B GTPase to the ciliary base to initiate ciliation.
KEGG: dre:619252
UniGene: Dr.77227
CEP19 is a 19 kDa centrosomal protein that localizes to the distal end of the mother centriole. In vertebrates, it forms a functional module with FOP and CEP350 to drive the early steps of ciliogenesis . The C-terminus of CEP19 is crucial for both its localization to centrioles and its function in ciliogenesis, as this region mediates the interaction between CEP19 and its binding partners FOP/CEP350 .
While specific structural data for Danio rerio CEP19 is limited, the protein likely shares considerable homology with human CEP19 given the conservation of centrosomal proteins across vertebrate species. Functional studies suggest that CEP19 plays a critical role in the docking of ciliary vesicles to the distal end of mother centrioles, a crucial step in cilia formation .
Methodological answer: To determine cep19 expression patterns during zebrafish development, researchers typically employ:
Quantitative RT-PCR at different developmental stages (0-72 hpf)
Whole-mount in situ hybridization to visualize spatial expression
Immunofluorescence with anti-CEP19 antibodies
While the search results don't provide specific data on zebrafish cep19 expression patterns, researchers should examine expression in ciliated tissues such as pronephric ducts, neural tube, and sensory organs like the otic vesicle, which typically express centrosomal proteins involved in ciliogenesis.
For efficient production of recombinant Danio rerio CEP19, bacterial expression systems using E. coli are commonly employed for initial characterization studies. Based on established protocols for recombinant protein expression in zebrafish, the following methodological approach is recommended:
Clone the cep19 coding sequence into an in vivo/in vitro compatible vector such as pIVEX (similar to approaches used for other Danio rerio proteins)
Transform into an E. coli expression strain (BL21(DE3) or Rosetta)
Induce expression with IPTG (0.5-1 mM) at lower temperatures (16-18°C) to enhance proper folding
Include a fusion tag (His6, GST, or MBP) to facilitate purification and potentially improve solubility
For functional studies requiring post-translational modifications, consider:
Baculovirus expression systems in insect cells
Mammalian expression systems (HEK293T, CHO cells)
Purification of functional recombinant CEP19 presents several challenges that researchers should address:
Solubility issues: CEP19 may form inclusion bodies in bacterial systems. To overcome this:
Use solubility-enhancing fusion partners (MBP, SUMO)
Optimize induction conditions (lower temperature, reduced IPTG concentration)
Employ specialized E. coli strains designed for difficult-to-express proteins
Maintaining protein-protein interaction capabilities: Since CEP19 functions through interactions with partners like FOP and CEP350 , preserving the native conformation is crucial:
Include stabilizing agents in purification buffers (glycerol 5-10%, reducing agents)
Consider mild detergents if membrane-association is suspected
Validate functionality through binding assays with known partners
Preserving the critical C-terminal domain: The C-terminus of CEP19 is essential for its localization and function . Ensure that:
C-terminal tags don't interfere with function
Proteolytic degradation is minimized during purification
The integrity of the C-terminus is verified by mass spectrometry
Methodological approach for investigating CEP19's role in ciliogenesis:
Generate CEP19-deficient zebrafish models:
CRISPR/Cas9 knockout targeting the cep19 gene
Morpholino-based knockdown for transient loss of function
Rescue experiments using wild-type and mutant CEP19 constructs
Analyze cilia formation and function:
Immunofluorescence microscopy using antibodies against:
Transmission electron microscopy to examine:
Ciliary vesicle docking to mother centrioles
Basal body ultrastructure
Ciliary transition zone formation
Assess physiological impact:
Examine left-right asymmetry defects (heart looping)
Evaluate kidney function (pronephric cysts)
Test for sensory deficits (otic vesicle development, lateral line formation)
These approaches parallel methods used in studies of CEP19 knockout cells, where defects in ciliary vesicle docking to the distal end of mother centrioles were observed .
To investigate the CEP19-FOP-CEP350 interaction network in zebrafish cells, researchers should employ multiple complementary approaches:
Biochemical interaction studies:
Co-immunoprecipitation of endogenous proteins
GST pulldown assays using recombinant proteins
Yeast two-hybrid screening to identify additional interactors
Proximity labeling methods (BioID, APEX) to identify the broader interactome
Advanced microscopy techniques:
Three-dimensional structured-illumination microscopy (3D-SIM) to map the relative spatial distribution of CEP19, FOP, and CEP350 at the distal end of the mother centriole
Super-resolution microscopy (STORM, PALM) for nanoscale localization
Live-cell imaging with fluorescently tagged proteins to track recruitment dynamics
Functional dissection:
Sequential knockdown/knockout experiments to establish the recruitment hierarchy
Expression of deletion mutants to identify critical interaction domains
Point mutations in key residues to disrupt specific interactions
Studies in other systems have shown that CEP350/FOP act upstream of CEP19 in their recruitment hierarchy, and the C-terminus of CEP19 mediates the interaction between CEP19 and FOP/CEP350 .
Zebrafish models of CEP19 deficiency can provide valuable insights into obesity mechanisms based on the association between CEP19 mutations and morbid obesity in humans :
Generation of disease-relevant models:
CRISPR/Cas9 knock-in of the human R82* mutation associated with obesity
Analyze phenotypic consequences throughout development and in adult fish
Metabolic assessments:
Quantify adipose tissue accumulation using:
Oil Red O staining
Fluorescent lipid reporters
Micro-CT imaging for 3D visualization
Measure metabolic parameters:
Glucose tolerance tests
Lipid profiles (triglycerides, cholesterol)
Oxygen consumption and energy expenditure
Molecular pathway analysis:
RNA-seq to identify dysregulated metabolic pathways
Phosphoproteomics to detect altered signaling cascades
Investigate ciliary signaling pathways (Hedgehog, Wnt) that may link ciliary dysfunction to metabolic disorders
This approach leverages the benefits of zebrafish models (rapid development, optical transparency, genetic tractability) while addressing the clinical features observed in patients with CEP19 deficiency, including decreased HDL cholesterol, hypercholesterolemia, and hypertriglyceridemia .
The relationship between CEP19 mutations and ciliopathies can be explored through comparative analysis across vertebrate models, including zebrafish:
Phenotypic spectrum analysis:
Compare phenotypes of CEP19-deficient zebrafish with known ciliopathy models
Assess specific tissues where primary cilia are critical:
Neural tube (Hedgehog signaling)
Kidney (fluid flow sensing)
Eye (photoreceptor development)
Brain (neuronal migration)
Mechanistic investigations:
Rescue experiments:
Test whether human CEP19 can rescue zebrafish cep19 deficiency
Introduce known human mutations (e.g., R82*) and assess their ability to complement loss of function
Evaluate whether overexpression of interacting partners (FOP, CEP350) can compensate for CEP19 deficiency
This research is particularly relevant given that ciliopathies represent a growing spectrum of disorders, and CEP19's role in ciliary vesicle docking positions it as a potential contributor to this disease category .
While specific data on post-translational modifications (PTMs) of zebrafish CEP19 is limited, researchers should consider the following methodological approaches to study PTMs:
Identification of PTMs:
Mass spectrometry analysis of immunoprecipitated endogenous CEP19
Site-directed mutagenesis of predicted modification sites
Phospho-specific or ubiquitin-specific antibodies
Cell cycle regulation:
Functional consequences:
Generate phosphomimetic and phospho-dead mutants
Assess impact on:
Based on studies of other centrosomal proteins like pericentrin (PCNT), researchers should investigate whether CEP19 mRNA undergoes spatial localization:
mRNA localization analysis:
Translation-dependent localization mechanisms:
Co-translational targeting hypothesis testing:
Polysome profiling to detect actively translating cep19 mRNA
Proximity-specific ribosome profiling near centrosomes
Pulse-chase experiments to track newly synthesized CEP19 protein
This investigation would parallel findings for pericentrin, where mRNA is delivered co-translationally to centrosomes during early mitosis by cytoplasmic dynein, facilitating efficient protein incorporation during centrosome maturation .
To assess the evolutionary conservation of CEP19 across vertebrates, researchers should employ:
Sequence analysis methods:
Multiple sequence alignment of CEP19 orthologs from diverse vertebrates
Phylogenetic tree construction to visualize evolutionary relationships
Conservation mapping onto predicted structural domains
Functional conservation testing:
Cross-species complementation assays (can human CEP19 rescue zebrafish phenotypes?)
Domain swapping experiments between zebrafish and human CEP19
Identification of conserved interaction interfaces with FOP and CEP350
Structural comparison:
Homology modeling of Danio rerio CEP19 based on structural data from other species
Comparison of predicted C2 domains, similar to those found in other centrosomal proteins
Analysis of conserved regions that might be critical for ciliary vesicle docking
This comparative approach would provide insights into which domains of CEP19 are under evolutionary constraint, potentially highlighting functionally critical regions beyond the known C-terminal domain that mediates interactions with FOP and CEP350 .
A comprehensive analysis of divergent features between zebrafish and mammalian CEP19 would include: